论文信息 - LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816 - 字舞流文

LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816

J. Taube | P. Illei | E. Gabrielson | A. Cimino-Mathews | P. Forde | T. Cottrell | J. Spicer | J. Fiore | D. Pandya | M. P. Pulla | J. Jedrych | J. S. Deutsch | D. Wang | A. Baras | E. D. Thompson | V. Devas | R. Anders | L. Danilova | M. Tran